News
ArrayPatch microneedle project awarded the Enterprise Ireland Commercialization Fund
Congratulations to Dr Waleed Faisal and his team, winners of the Enterprise Ireland Commercialization Fund in Pharmacy.
It's fantastic to see one of the School's research teams awarded Enterprise Ireland commercialisation funding to carry out feasibility and technological development and to transform commercially relevant research into investable high potential start-ups.
Dr Waleed Faisal has been awarded €738k by Enterprise Ireland (EI) to develop a medicated ‘band-aid’ to treat fungal infections of the fingernails and toenails (onychomycosis). ArrayPatch aims to take a slice of the global onychomycosis treatment market currently worth US$4.5 billion. In the last 4 years, this patent microneedle technology attracted a total fund of €1.34M. UCC Innovation expects to establish a spinout company around this technology within 18 months, with the anti-fungal patch anticipated to hit the pharmacy shelves within 4-5 years when clinical trials are completed.
This is a strong example of the kind of research that goes on in the School of Pharmacy: exciting new developments in disruptive technologies resulting in a positive, global impact.